Going back to their discovery in the early 1980s, both the Human T-cell Leukemia virus type-
1 (HTLV-1) and the Human Immunodeficiency Virus type-1 (HIV-1) greatly fascinated the …

The human T cell leukemic/lymphotropic virus type 1 (HTLV-1), discovered several years
ago, is the causative agent for a rapid progressive haematological malignancy, adult T cell …

Human T cell leukemia virus type 1 (HTLV-1) was the first discovered human retrovirus and
the etiologic agent of adult T-cell leukemia and HTLV-1-associated myelopathy/tropical …

Human T cell leukemia virus type 1 (HTLV-1), also known as human T lymphotropic virus
type 1, was the first exogenous human retrovirus discovered. Unlike the distantly related …

It has been nearly 40 years since human T-cell leukemia virus-1 (HTLV-1), the first
oncogenic retrovirus in humans and the first demonstrable cause of cancer by an infectious …

Even though an estimated 10–20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …

Human T-cell leukaemia virus 1 (HTLV-1) is the most potent carcinogenic oncovirus and
potentially the most oncogenic risk factor including chem ical carcinogens. 1 A unique and …

HTLV-1 is a retrovirus that causes lifelong T-cell infection in humans, impacting the host
immune response. This virus causes a range of clinical manifestations, from inflammatory …

After the discovery of retroviral reverse transcriptase in 1970, there was a flurry of activity,
sparked by the “War on Cancer,” to identify human cancer retroviruses. After many false …

Background Human T cell leukaemia virus type 1 (HTLV-1) is a retrovirus associated with
human diseases such as adult T-cell leukaemia/lymphoma and HTLV-1 associated …